Trump Administration Backs Down on an Opioid Ban After Kratom Industry Lobbying

Health officials will now allow some levels of a powerful substance derived from the kratom plant to remain in products marketed as natural. This change followed lobbying efforts from the kratom industry and could affect a Republican donor facing wrongful death lawsuits.